☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Tablets
Astellas Reports the US FDA's Acceptance of Priority Review for its NDO Therapy
January 7, 2021
Zydus' Doxycycline Hyclate Delayed-Release Tablets USP and Febuxostat Tablets Receives FDA's Approval
December 27, 2018
Horizon's Procysbi (Cysteamine Bitartrate) Receives the US FDA's Approval for Delayed Release Oral Tablets
February 18, 2020
Zydus' Doxycycline Hyclate Delayed-Release Tablets USP and Febuxostat Tablets Receives FDA's Approval
December 27, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.